PROMETHEUS BIOSCIENCES, INC. Conversion of Stock, Amount Converted
PROMETHEUS BIOSCIENCES, INC. reported Conversion of Stock, Amount Converted of $210.81 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2023-02-28
- PROMETHEUS BIOSCIENCES, INC. conversion of stock, amount converted for the quarter ending 2021-12-31 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. conversion of stock, amount converted for the quarter ending 2021-09-30 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. conversion of stock, amount converted for the quarter ending 2021-06-30 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. conversion of stock, amount converted for the quarter ending 2021-03-31 was $210.81M.
- PROMETHEUS BIOSCIENCES, INC. conversion of stock, amount converted for fiscal 2021 was $210.81M.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $210.81M 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $210.81M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $210.81M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $210.81M 10-Q · filed 2022-05-12 |